Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trigeminal Ganglion | 2 | 2021 | 15 | 1.280 |
Why?
|
| Calcitonin Gene-Related Peptide | 2 | 2021 | 39 | 1.280 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2021 | 118 | 1.220 |
Why?
|
| Oxidative Stress | 2 | 2021 | 489 | 1.020 |
Why?
|
| Neurons | 8 | 2020 | 1621 | 0.740 |
Why?
|
| Nitroglycerin | 1 | 2021 | 24 | 0.670 |
Why?
|
| Migraine Disorders | 1 | 2021 | 42 | 0.640 |
Why?
|
| Levodopa | 4 | 2015 | 38 | 0.570 |
Why?
|
| Dyskinesia, Drug-Induced | 3 | 2015 | 19 | 0.530 |
Why?
|
| Antiparkinson Agents | 2 | 2014 | 18 | 0.470 |
Why?
|
| Parkinsonian Disorders | 2 | 2014 | 24 | 0.470 |
Why?
|
| Neostriatum | 1 | 2014 | 23 | 0.410 |
Why?
|
| Parasympathetic Nervous System | 1 | 2014 | 34 | 0.410 |
Why?
|
| Dopamine | 7 | 2010 | 280 | 0.210 |
Why?
|
| Rats | 2 | 2021 | 4073 | 0.210 |
Why?
|
| Serotonin | 2 | 2002 | 211 | 0.200 |
Why?
|
| Fetus | 2 | 2002 | 238 | 0.200 |
Why?
|
| Growth Substances | 1 | 2003 | 79 | 0.200 |
Why?
|
| Corpus Striatum | 4 | 2015 | 83 | 0.190 |
Why?
|
| Serotonin Agents | 1 | 2002 | 14 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2021 | 66 | 0.180 |
Why?
|
| Methamphetamine | 2 | 2002 | 111 | 0.180 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2002 | 29 | 0.170 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2002 | 80 | 0.170 |
Why?
|
| Animals | 13 | 2021 | 28950 | 0.160 |
Why?
|
| Administration, Intranasal | 1 | 2021 | 141 | 0.160 |
Why?
|
| Parkinson Disease | 2 | 2015 | 186 | 0.160 |
Why?
|
| Rats, Wistar | 1 | 2021 | 304 | 0.160 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2002 | 185 | 0.160 |
Why?
|
| Receptors, Calcitonin Gene-Related Peptide | 1 | 2020 | 5 | 0.160 |
Why?
|
| Up-Regulation | 1 | 2002 | 743 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 7 | 2015 | 3612 | 0.140 |
Why?
|
| Mice | 11 | 2015 | 12718 | 0.120 |
Why?
|
| Immunohistochemistry | 4 | 2014 | 1816 | 0.120 |
Why?
|
| Receptors, Histamine H2 | 1 | 2015 | 4 | 0.110 |
Why?
|
| Cholinergic Neurons | 1 | 2015 | 14 | 0.110 |
Why?
|
| Hydroxydopamines | 1 | 2014 | 7 | 0.100 |
Why?
|
| Diphtheria Toxin | 1 | 2014 | 22 | 0.100 |
Why?
|
| Denervation | 1 | 2014 | 27 | 0.100 |
Why?
|
| DNA, Complementary | 1 | 2014 | 380 | 0.100 |
Why?
|
| Mice, Transgenic | 2 | 2014 | 1606 | 0.090 |
Why?
|
| Adenoviridae | 1 | 2014 | 340 | 0.090 |
Why?
|
| Aphakia | 2 | 2010 | 8 | 0.080 |
Why?
|
| Brain | 1 | 2002 | 2431 | 0.080 |
Why?
|
| Dyskinesias | 1 | 2010 | 10 | 0.080 |
Why?
|
| Cholinergic Fibers | 1 | 2010 | 23 | 0.080 |
Why?
|
| Behavior, Animal | 1 | 2014 | 398 | 0.080 |
Why?
|
| Mesencephalon | 2 | 2004 | 68 | 0.070 |
Why?
|
| Disease Models, Animal | 3 | 2015 | 2575 | 0.070 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2007 | 17 | 0.060 |
Why?
|
| Hybrid Cells | 3 | 2003 | 68 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2002 | 2856 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 1303 | 0.060 |
Why?
|
| Pregnancy | 3 | 2002 | 3266 | 0.060 |
Why?
|
| Cell Line | 3 | 2004 | 2482 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2004 | 145 | 0.050 |
Why?
|
| Cell Aggregation | 2 | 2002 | 38 | 0.050 |
Why?
|
| Female | 4 | 2021 | 51685 | 0.050 |
Why?
|
| Litter Size | 1 | 2002 | 13 | 0.050 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 2002 | 11 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 2020 | 0.040 |
Why?
|
| Cell Count | 1 | 2002 | 195 | 0.040 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 2002 | 27 | 0.040 |
Why?
|
| Homovanillic Acid | 1 | 2002 | 35 | 0.040 |
Why?
|
| Weight Gain | 1 | 2002 | 138 | 0.040 |
Why?
|
| Cell Survival | 1 | 2003 | 1016 | 0.040 |
Why?
|
| Pregnancy Complications | 1 | 2002 | 368 | 0.040 |
Why?
|
| Male | 1 | 2021 | 47195 | 0.030 |
Why?
|
| Famotidine | 1 | 2015 | 3 | 0.030 |
Why?
|
| Dicyclomine | 1 | 2015 | 4 | 0.030 |
Why?
|
| Histamine H2 Antagonists | 1 | 2015 | 12 | 0.030 |
Why?
|
| Acetylcholinesterase | 1 | 1995 | 42 | 0.030 |
Why?
|
| Receptors, Dopamine | 1 | 1995 | 32 | 0.030 |
Why?
|
| Acetylcholine | 1 | 1995 | 158 | 0.030 |
Why?
|
| Interneurons | 1 | 2015 | 103 | 0.030 |
Why?
|
| Action Potentials | 1 | 2015 | 611 | 0.020 |
Why?
|
| Aminoacetonitrile | 1 | 2010 | 3 | 0.020 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2010 | 25 | 0.020 |
Why?
|
| Adenosine A2 Receptor Antagonists | 1 | 2010 | 13 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2010 | 1145 | 0.020 |
Why?
|
| Dynorphins | 1 | 2007 | 14 | 0.020 |
Why?
|
| Enkephalins | 1 | 2007 | 14 | 0.020 |
Why?
|
| Substantia Nigra | 1 | 2007 | 28 | 0.020 |
Why?
|
| Afferent Pathways | 1 | 2007 | 61 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2010 | 568 | 0.020 |
Why?
|
| Protein Precursors | 1 | 2007 | 133 | 0.020 |
Why?
|
| Oleic Acid | 1 | 2004 | 15 | 0.010 |
Why?
|
| Oleic Acids | 1 | 2004 | 33 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2004 | 271 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2010 | 1717 | 0.010 |
Why?
|
| Culture Techniques | 2 | 1991 | 80 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 1946 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 5573 | 0.010 |
Why?
|
| Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 1995 | 6 | 0.010 |
Why?
|
| Adenylyl Cyclases | 1 | 1995 | 105 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 1995 | 264 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 1995 | 200 | 0.010 |
Why?
|
| Binding Sites | 1 | 1995 | 1159 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 1995 | 521 | 0.010 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 1 | 1991 | 9 | 0.010 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 1991 | 41 | 0.010 |
Why?
|
| Cell Fusion | 1 | 1991 | 34 | 0.010 |
Why?
|
| Neurofilament Proteins | 1 | 1991 | 19 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1991 | 122 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1991 | 110 | 0.010 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 1991 | 56 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1991 | 112 | 0.010 |
Why?
|
| Base Sequence | 1 | 1995 | 2222 | 0.010 |
Why?
|
| Clone Cells | 1 | 1991 | 221 | 0.010 |
Why?
|
| Catecholamines | 1 | 1991 | 93 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 1991 | 220 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1991 | 310 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1995 | 2894 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 1991 | 407 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1995 | 2068 | 0.000 |
Why?
|
| Biomarkers | 1 | 1995 | 2020 | 0.000 |
Why?
|
| Neuroblastoma | 1 | 1991 | 410 | 0.000 |
Why?
|